Key result
Catheter-based radiofrequency ablation is successful in approximately 60% to 70% of patients with atrial fibrillation, offering superior rhythm control compared to antiarrhythmic drugs.
Why the study?
Does catheter-based radiofrequency ablation improve maintenance of sinus rhythm in patients with atrial fibrillation?
Does catheter-based radiofrequency ablation improve maintenance of sinus rhythm in patients with atrial fibrillation?
Catheter ablation is an effective treatment for symptomatic atrial fibrillation refractory to antiarrhythmic drugs, but requires careful patient selection and understanding of procedural risks and the potential need for lifelong anticoagulation.
Answers are grounded in this paper and cite their sources.
Supports ablation for refractory symptomatic AF; leaves open optimal selection and anticoagulation needs.
Although catheter-based radiofrequency ablation is no longer experimental, it is not yet the first-line treatment for most patients. The authors describe how this procedure works, its indications, benefits, and limitations, and important points to communicate to potential candidates for this procedure.
No takes yet. Share an insight, caveat, or question.
Chowdhury et al. (2009) conducted a review in Atrial fibrillation. Catheter-based radiofrequency ablation vs. Antiarrhythmic drugs was evaluated. Catheter-based radiofrequency ablation is successful in approximately 60% to 70% of patients with atrial fibrillation, offering superior rhythm control compared to antiarrhythmic drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: